← Back to Search

Aerobic Exercise for Parkinson's Disease

N/A
Waitlist Available
Led By Merrill Landers, DPT, PhD
Research Sponsored by University of Nevada, Las Vegas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes prior to the exercise (pre measurement) and 30 minutes after completing the 30-minute aerobic exercise condition (post measurement) . both conditions are separated by one week
Awards & highlights

Study Summary

This trial explores how exercise can reduce inflammation in older adults and people with Parkinson's, which may slow the progression of the disease.

Who is the study for?
This trial is for people aged 30-85 with Parkinson's disease who can do 30 minutes of moderate exercise with short breaks, and healthy adults in the same age range. It excludes those with conditions like heart issues or uncontrolled blood pressure that prevent safe exercise, and those with dementia as indicated by a low score on a cognitive assessment.Check my eligibility
What is being tested?
The study investigates how aerobic exercise might protect brain cells from dying in Parkinson's disease by reducing inflammation. Participants will engage in regular moderate aerobic exercises to see if this slows down the progression of their condition.See study design
What are the potential side effects?
While not explicitly listed, potential side effects may include typical risks associated with moderate physical activity such as muscle soreness, fatigue, joint pain, or exacerbation of pre-existing conditions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline measurement only
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline measurement only for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biomarkers in Parkinson Disease
Exercise and inflammatory milieu
Exercise dose and biomarkers
+1 more

Trial Design

2Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
Older, adults who are age- and sex-matched to the PD participants.
Group II: Parkinson DiseaseActive Control1 Intervention
Participants diagnosed with Parkinson disease (PD) will the main arm of the study and will be compared to the control group.

Find a Location

Who is running the clinical trial?

University of Nevada, Las VegasLead Sponsor
66 Previous Clinical Trials
13,709 Total Patients Enrolled
Merrill Landers, DPT, PhDPrincipal InvestigatorUniversity of Nevada, Las Vegas
1 Previous Clinical Trials
300 Total Patients Enrolled

Media Library

Aerobic exercise Clinical Trial Eligibility Overview. Trial Name: NCT05854524 — N/A
Parkinson's Disease Research Study Groups: Control, Parkinson Disease
Parkinson's Disease Clinical Trial 2023: Aerobic exercise Highlights & Side Effects. Trial Name: NCT05854524 — N/A
Aerobic exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05854524 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants over the age of 18 being sought for this research?

"This clinical trial allows for the enrolment of patients between 30 and 85 years old. There are 26 studies available specifically for those younger than 18, while 505 research projects exist for individuals over 65."

Answered by AI

Is there still availability for people to join this research experiment?

"The clinical trial in question is not currently recruiting patients, as indicated on the official clinicaltrials.gov database. This particular study was posted on July 1st 2023 and last modified on May 2nd 2023; however, there are 508 other trials that are actively searching for participants presently."

Answered by AI
~60 spots leftby May 2026